KIMIABLPharmaceuticals

Kimia Biosciences LtdQuarterly Results & Earnings

23.55
-10.89%
Profit Growth YoY-36.65%Latest quarter
Sales Growth YoY20.65%Latest quarter
Sales CAGR 5Y2.27%5 year compound
Profit CAGR 5Y47.21%5 year compound
📋

Quarterly Performance

YoY Profit Growth-36.65%
🔴 Significant decline
YoY Sales Growth+20.65%
🔥 Exceptional growth
OPM 5Y Average
Operating profit margin
3.90%
EPS Growth 5Y
46.61%
Interest Coverage
Higher = safer debt servicing
3.61
ROE
186.78%
ROCE
41.80%
💡

Growth Analysis

Kimia Biosciences Ltd reported YoY profit growth of -36.65% and revenue growth of 20.65% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at 2.27% and profits at 47.21% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.